Effects of sodium hyaluronate and methylprednisolone acetate on proteoglycan synthesis in equine articular cartilage explants.

The research explores the impacts of sodium hyaluronate (HA) on the metabolization of cartilage matrix induced by corticosteroids in horse joint cartilage. The investigation reveals minimal preventative effects by HA on cartilage matrix degradation caused by corticosteroids.

Research Methodology

• The researchers used 30 articular cartilage explants from fetlock joints of five adult horses showing no signs of joint disease. Fetlock joints are a common area in horses to study cartilage-related issues as they bear most of the horse’s weight.
• The explants were treated with either a control medium, a medium containing methylprednisolone acetate (MPA), HA, or both.
• Proteoglycan (PG) synthesis was followed by incorporation of sulfur 35-labeled sodium sulfate into PGs.
• PG degradation was tracked by measuring the release of radiolabeled PGs into the culture medium.
• The total glycosaminoglycan (GAG) content in media and explants, as well as the total explant DNA, was also determined to track the changes in cartilage structure and cellularity.

Research Findings

• It was found that MPA led to a decrease in PG synthesis, whereas HA did not have any effect.
• The combination of MPA at a concentration of 0.05 mg/mL and HA at a concentration of 1.0 mg/mL increased PG synthesis, as compared to control explants.
• MPA also increased the degradation of PGs into the medium, but HA alone did not affect this process.
• HA had no impact on the PG degradation induced by MPA and its release into the media.
• Neither MPA alone nor HA alone had an effect on total cartilage GAG content.
• But MPA did cause an increase in the release of GAG into the medium at 48 and 72 hours after treatment.
• However, the total cartilage DNA content was not affected by the treatments, suggesting that the drugs don’t significantly alter cellularity within the cartilage.

Conclusion

The experiment concluded that adding HA has little preventative effect on the corticosteroid-induced catabolism of the cartilage matrix in the articular cartilage explants. It suggests that while HA has essential biological roles, as an isolated therapeutic drug, it might not be sufficient to protect cartilage structure when corticosteroids are present.